ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
Neuren commences Phase 2 trials of NNZ-2591 in PMS and PTHS
Published: 08/08/22, 09:14am (AEST)•3 pages